← Back to Clinical Trials
Recruiting NCT06394440

NCT06394440 Clinical Evaluation of Self-Adhesive Bulk-Fill Composite Versus Conventional Nano-hybrid Composite in Cervical Cavities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06394440
Status Recruiting
Phase
Sponsor Misr International University
Condition Cervical Caries
Study Type INTERVENTIONAL
Enrollment 54 participants
Start Date 2023-03-14
Primary Completion 2024-07-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Self-Adhesive Bulkfill Composite (Surefil One)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 54 participants in total. It began in 2023-03-14 with a primary completion date of 2024-07-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this randomized clinical trial is to compare the six months clinical performance of the self-adhesive bulk-fill composite with the conventional nano-hybrid composite in the cervical lesions of teeth in the esthetic zone. In addition, to evaluate patient's satisfaction towards the self-adhesive bulk-fill material and its total operatory time.

Eligibility Criteria

Inclusion Criteria: * Cervical lesions. * Cervical lesions of at least one mm depth; to include enamel and dentin. * Cervical lesions of not more than 3 mm in depth. * Male or female genders. * Medically free patients. * Normal occlusion. * Healthy Gingiva Exclusion Criteria: * Teeth showing signs of pulpitis or periapical pathosis. * Patients older than 60 years. * Patients younger than 18 years old. * Pregnant women. * Patients with history of allergy to resin. * Patients with disabilities. * Carious cervical lesions extending to proximal surfaces. * Carious cervical lesions on the palatal/lingual surfaces. * Teeth with root caries. * Endodontically treated teeth.

Frequently Asked Questions

Who can join the NCT06394440 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Cervical Caries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06394440 currently recruiting?

Yes, NCT06394440 is actively recruiting participants. Visit ClinicalTrials.gov or contact Misr International University to inquire about joining.

Where is the NCT06394440 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06394440 clinical trial?

NCT06394440 is sponsored by Misr International University. The trial plans to enroll 54 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology